These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 3893275)

  • 61. [Influence of alpha-thalassemia on the hematologic expression of homozygote drepanocytosis].
    de Montalembert M; Dode C; Maier-Redelsperger M; Labie D; Girot R
    Arch Fr Pediatr; 1987; 44(7):517-9. PubMed ID: 3426374
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sickle cell disease as a cause of osteonecrosis of the femoral head.
    Milner PF; Kraus AP; Sebes JI; Sleeper LA; Dukes KA; Embury SH; Bellevue R; Koshy M; Moohr JW; Smith J
    N Engl J Med; 1991 Nov; 325(21):1476-81. PubMed ID: 1944426
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intracellular polymerization. Disease severity and therapeutic predictions.
    Noguchi CT; Rodgers GP; Schechter AN
    Ann N Y Acad Sci; 1989; 565():75-82. PubMed ID: 2476066
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of alpha-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait.
    Gupta AK; Kirchner KA; Nicholson R; Adams JG; Schechter AN; Noguchi CT; Steinberg MH
    J Clin Invest; 1991 Dec; 88(6):1963-8. PubMed ID: 1752955
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Review: the sickle hemoglobinopathies--genetic analyses of common phenocopies and new molecular approaches to treatment.
    Steinberg MH
    Am J Med Sci; 1984 Nov; 288(4):169-74. PubMed ID: 6208780
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Compound Heterozygosity of β-Thalassemia and the Sickle Cell Hemoglobin in Various Populations of Chhattisgarh State, India.
    Jha AN; Mishra H; Verma HK; Pandey I; Lakkakula BVKS
    Hemoglobin; 2018 Mar; 42(2):84-90. PubMed ID: 30200838
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Studies on sickle cell heterozygotes in Saudi Arabia--interaction with alpha-thalassaemia.
    el-Hazmi MA
    Acta Haematol; 1986; 75(2):100-4. PubMed ID: 3090815
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rate of deoxygenation modulates rheologic behavior of sickle red blood cells at a given mean corpuscular hemoglobin concentration.
    Kaul DK; Liu XD
    Clin Hemorheol Microcirc; 1999; 21(2):125-35. PubMed ID: 10599596
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The interactions of alpha-thalassemia with hemoglobinopathies.
    Steinberg MH
    Hematol Oncol Clin North Am; 1991 Jun; 5(3):453-73. PubMed ID: 1864819
    [TBL] [Abstract][Full Text] [Related]  

  • 70. alpha-thalassemia in Bantu population from Congo-Brazzaville: its interaction with sickle cell anemia.
    Mouélé R; Pambou O; Feingold J; Galactéros F
    Hum Hered; 2000; 50(2):118-25. PubMed ID: 10799970
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Association between sickle cell anemia and alpha thalassemia reveals a high prevalence of the α
    Mikobi TM; Lukusa PT; Aloni MN; Lumaka A; Akilimali PZ; Devriendt K; Matthijs G; Mbuyi Muamba JM; Race V
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28276593
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Beta s-gene-cluster haplotypes in sickle cell anemia. Clinical and hematologic features.
    Powars DR
    Hematol Oncol Clin North Am; 1991 Jun; 5(3):475-93. PubMed ID: 1713910
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Correction of the sickle cell mutation in embryonic stem cells.
    Chang JC; Ye L; Kan YW
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1036-40. PubMed ID: 16407095
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Alpha-thalassemia in a pool of individuals of Eti-Turk origin with hemoglobin S (Hb S).
    Jama H; Gürgey A; Altay C
    Turk J Pediatr; 1987; 29(1):1-14. PubMed ID: 3433374
    [No Abstract]   [Full Text] [Related]  

  • 75. Sickle cell syndromes. III. Silent-carrier alpha-thalassemia in combination with hemoglobin S and hemoglobin C.
    Honig GR; Mason RG; Tremaine LM; Vida LN
    Pediatr Res; 1979 Oct; 13(10):1109-11. PubMed ID: 503635
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
    Rodgers GP
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rheologic predictors of the severity of the painful sickle cell crisis.
    Ballas SK; Larner J; Smith ED; Surrey S; Schwartz E; Rappaport EF
    Blood; 1988 Oct; 72(4):1216-23. PubMed ID: 3167204
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of thalassemia and microcytosis on the hematologic and vasoocclusive severity of sickle cell anemia.
    Steinberg MH; Rosenstock W; Coleman MB; Adams JG; Platica O; Cedeno M; Rieder RF; Wilson JT; Milner P; West S
    Blood; 1984 Jun; 63(6):1353-60. PubMed ID: 6722353
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Study of alpha hemoglobin stabilizing protein expression in patients with β thalassemia and sickle cell anemia and its impact on clinical severity.
    Mahmoud HM; Shoeib AA; Abd El Ghany SM; Reda MM; Ragab IA
    Blood Cells Mol Dis; 2015 Dec; 55(4):358-62. PubMed ID: 26460260
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cerebral hemodynamics and metabolism are similar in sickle cell disease patients with hemoglobin SS and Sβ
    Ikwuanusi I; Jordan LC; Lee CA; Patel NJ; Waddle S; Pruthi S; Davis LT; Griffin A; DeBaun MR; Kassim AA; Donahue MJ
    Am J Hematol; 2020 Mar; 95(3):E66-E68. PubMed ID: 31814164
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.